Seven Voting Members, Chair Revisit Silicone Implant Panel
This article was originally published in The Gray Sheet
Executive Summary
Previous silicone implant panelist Michael Miller, MD, will return to the General & Plastic Surgery Devices Panel April 11-13 to evaluate Inamed's and Mentor's premarket approval applications, despite conflict of interest allegations in 2003
You may also be interested in...
User Fee Revenue Sums Would Be Unknown By FDA Under House Proposal
A FDL-1bill pending in the House Energy & Commerce Committee would allocate all FDA user fee revenue to a general Treasury fund
User Fee Revenue Sums Would Be Unknown By FDA Under House Proposal
A FDL-1bill pending in the House Energy & Commerce Committee would allocate all FDA user fee revenue to a general Treasury fund
FDA Silicone Breast Implant Review Moves Forward, Despite CoI Objections
Michael Miller's contributions to the FDA General & Plastic Surgery Devices Panel's recent silicone-filled breast implant review outweigh any alleged conflict of interest, the agency maintains